Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C].

Zhonghua nei ke za zhi - 1 Jan 2012

Sun Li-jie, Yu Jian-wu, Kang Peng, Zhao Yong-hua, Yan Bing-zhu

Abstract excerpt

OBJECTIVE: To investigate the correlation between neutropenia (ANC) incidence and infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. METHODS: A retrospective cohort study of 399 patients treated with peginterferon and ribavirin derived from database of Depar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic
Share to Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Leukocyte Count

Share to Neutropenia

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 22490760

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22490760-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

[A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C].PMID 22490760Read ↗

Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.Semantic proximity Read ↗

Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: a preliminary report on treatment, safety and efficacy.Semantic proximity Read ↗

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.Semantic proximity Read ↗

Susceptibility to infection in patients with neutropenia: the role of the innate immune system.Semantic proximity Read ↗

Safety and efficacy of systematic administration of Filgrastim to prevent neutropenia and infections in patient with hepatitis C.Semantic proximity Read ↗

Neutropenia and viral load decline during treatment of hepatitis C virus genotype-4.Semantic proximity Read ↗

[Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1].Semantic proximity Read ↗

[An open-label pilot study evaluating the efficacy and safety of peginterferon alfa-2a combined with ribavirin in children with chronic hepatitis C].Semantic proximity Read ↗

Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.